Review
doi: 10.1111/j.1365-2141.2007.06909.x.
Familial myelodysplasia and acute myeloid leukaemia--a review
Affiliations
- PMID: 18173751
- DOI: 10.1111/j.1365-2141.2007.06909.x
Item in Clipboard
Review
Familial myelodysplasia and acute myeloid leukaemia--a review
Br J Haematol.
2008 Jan.
Free article
Abstract
Familial occurrence of myelodysplasia (MDS) and/or acute myeloid leukaemia (AML) is rare but can provide a useful resource for the investigation of predisposing mutations in these myeloid malignancies. To date, examination of families with MDS/AML has lead to the detection of two culprit genes, RUNX1 and CEBPA. Germline mutations in RUNX1 result in familial platelet disorder with propensity to myeloid malignancy and inherited mutations of CEBPA predispose to AML. Unfortunately, the genetic cause remains obscure in most other reported pedigrees. Further insight into the molecular mechanisms of familial MDS/AML will require awareness by clinicians of new patients with relevant family histories.
Similar articles
-
Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.J Clin Oncol. 2008 Nov 1;26(31):5088-93. doi: 10.1200/JCO.2008.16.5563. Epub 2008 Sep 2. J Clin Oncol. 2008. PMID: 18768433
-
Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations.J Cell Biochem. 2011 Feb;112(2):425-32. doi: 10.1002/jcb.22974. J Cell Biochem. 2011. PMID: 21268063
-
Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.Genes Chromosomes Cancer. 2004 Jul;40(3):165-71. doi: 10.1002/gcc.20030. Genes Chromosomes Cancer. 2004. PMID: 15138996
-
[Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].Orv Hetil. 2016 Feb 21;157(8):283-9. doi: 10.1556/650.2016.30375. Orv Hetil. 2016. PMID: 26876264 Review. Hungarian.
-
Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.J Cell Physiol. 2009 Jul;220(1):16-20. doi: 10.1002/jcp.21769. J Cell Physiol. 2009. PMID: 19334039 Review.
Cited by
-
Acute myeloid leukemia: survival analysis of patients at a university hospital of Paraná.Rev Bras Hematol Hemoter. 2015 Jan-Feb;37(1):21-7. doi: 10.1016/j.bjhh.2014.11.008. Epub 2014 Nov 21. Rev Bras Hematol Hemoter. 2015. PMID: 25638763 Free PMC article.
-
Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia.Oncotarget. 2016 Oct 4;7(40):66255-66266. doi: 10.18632/oncotarget.11357. Oncotarget. 2016. PMID: 27542261 Free PMC article. Review.
-
Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia.Leukemia. 2015 Aug;29(8):1795-7. doi: 10.1038/leu.2015.40. Epub 2015 Feb 13. Leukemia. 2015. PMID: 25676417 No abstract available.
-
Germline PAX5 mutations and B cell leukemia.Nat Genet. 2013 Oct;45(10):1104-5. doi: 10.1038/ng.2778. Nat Genet. 2013. PMID: 24071841
-
RUNX1 Mutations in Inherited and Sporadic Leukemia.Front Cell Dev Biol. 2017 Dec 20;5:111. doi: 10.3389/fcell.2017.00111. eCollection 2017. Front Cell Dev Biol. 2017. PMID: 29326930 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
